Amerise Biosciences FY26 Net Profit ₹1.61 Lakhs

• Amerise Biosciences reported audited FY26 net profit of ₹1.61 lakhs, up from ₹0.57 lakhs in FY25.
• Total income for FY26 was ₹25.52 lakhs, primarily from other operating revenue, with expenses of ₹23.46 lakhs.
• The board meeting on May 5, 2026, approved financial results with an unmodified audit opinion from Bipin & Co.
• Company maintained paid-up equity share capital of ₹660.69 lakhs with negative other equity of ₹(121.10) lakhs.